Beneficial Ownership Report – Form SC 13G
SECURITIES AND EXCHANGE COMMISSION
SCHEDULE 13G
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO § 240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED
PURSUANT TO § 240.13d-2
(Amendment No. )
(
COMMON STOCK
(Title of Class of Securities)
H1467J104
(CUSIP Number)
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
☒ Rule 13d-1 (b)
☐ Rule 13d-1 (c)
☐ Rule 13d-1 (d)
* |
The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. |
The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 (the "Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes.)
CUSIP No. H1467J104 | 13G | Page 2 of 8 Pages |
1 |
NAME OF REPORTING PERSON |
|
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☒ (b) ☐ |
|
3 |
SEC USE ONLY |
|
4 |
CITIZENSHIP OR PLACE OF ORGANIZATION United States Citizen |
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
5 |
SOLE VOTING POWER NONE |
||
6 |
SHARED VOTING POWER 27,033,784 shares of Common Stock |
|||
7 |
SOLE DISPOSITIVE POWER NONE |
|||
8 |
SHARED DISPOSITIVE POWER 27,033,784 shares of Common Stock |
9 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 27,033,784 shares of Common Stock |
|
10 |
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ☐ Not Applicable. |
|
11 |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 6.7% |
|
12 |
TYPE OF REPORTING PERSON IN |
CUSIP No. H1467J104 | 13G | Page 3 of 8 Pages |
1 |
NAME OF REPORTING PERSON |
|
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☒ (b) ☐ |
|
3 |
SEC USE ONLY |
|
4 |
CITIZENSHIP OR PLACE OF ORGANIZATION |
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
5 |
SOLE VOTING POWER NONE |
||
6 |
SHARED VOTING POWER 27,033,784 shares of Common Stock |
|||
7 |
SOLE DISPOSITIVE POWER NONE |
|||
8 |
SHARED DISPOSITIVE POWER 27,033,784 shares of Common Stock |
9 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 27,033,784 shares of Common Stock |
|
10 |
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ☐ Not applicable. |
|
11 |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 6.7% |
|
12 |
TYPE OF REPORTING PERSON HC, CO |
CUSIP No. H1467J104 | 13G | Page 4 of 8 Pages |
1 |
NAME OF REPORTING PERSON |
|
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☒ (b) ☐ |
|
3 |
SEC USE ONLY |
|
4 |
CITIZENSHIP OR PLACE OF ORGANIZATION |
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
5 |
SOLE VOTING POWER NONE |
||
6 |
SHARED VOTING POWER 27,033,784 shares of Common Stock |
|||
7 |
SOLE DISPOSITIVE POWER NONE |
|||
8 |
SHARED DISPOSITIVE POWER 27,033,784 shares of Common Stock |
9 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 27,033,784 shares of Common Stock |
|
10 |
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ☐ Not applicable. |
|
11 |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 6.7% |
|
12 |
TYPE OF REPORTING PERSON |
Page 5 of 8 Pages |
Item 1.
(a) |
|
(b) |
Address of Issuer's Principal Executive Offices |
BARENGASSE 32,
Item 2(a).
Item 2(b). Address of Principal Business Office:
Item 2(c). Citizenship:
United States Citizen |
|
Page 6 of 8 Pages |
(d) |
Title of Class of Securities |
Common Stock
(e) |
CUSIP Number |
H1467J104
Item 3. If this statement is filed pursuant to § 240.13d-1(b), or § 240.13d-2(b) or (c), check whether the person filing is a:
Item 4. Ownership
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
(a) |
Amount beneficially Owned |
See the Cover Pages for each of the Reporting Persons.
(b) |
Percent of Class |
See the Cover Pages for each of the Reporting Persons.
(c) |
Number of shares as to which such person has: |
(i) |
sole power to vote or to direct the vote |
(ii) |
shared power to vote or to direct the vote |
Page 7 of 8 Pages |
(iii) |
sole power to dispose or to direct the disposition of |
(iv) |
shared power to dispose or to direct the disposition of |
See the Cover Pages for each of the Reporting Persons.
Item 5. Ownership of Five Percent or Less of a Class.
Not Applicable.
Item 6. Ownership of More than Five Percent on Behalf of Another Person.
Not Applicable.
Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the
See Exhibit A.
Item 8. Identification and Classification of Members of the Group.
See Exhibit A.
Item 9. Notice of Dissolution of Group.
Not Applicable.
Item 10. Certification.
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
Page 8 of 8 Pages |
SIGNATURES
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Dated this 14th day of November, 2024
/s/ |
||
By: | /s/ |
|
Chairman of the Board | ||
By: | /s/ |
|
Attorney-in-Fact |
Attachments
Disclaimer
Researchers from Temple University Hospital & Medical School Discuss Findings in Managed Care [Dwindling Dollars: the Inflation-adjusted Decline of Medicare Reimbursement In Endocrine Surgery (2003-2023)]: Managed Care
Studies from University of Maryland Have Provided New Information about Managed Care and Specialty Pharmacy (Impact of Manufacturer-initiated List Price Reduction On Patient Out-of-pocket Costs For <i> Pcsk9 </i> Inhibitors): Drugs and Therapies – Managed Care and Specialty Pharmacy
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News